News Room
Want to know the latest about Avantra Biosciences? Visit our press room often to learn the latest developments about our growing company, including speaking engagement and trade show exhibitions.

Latest News

The AVANTRA used in NCI's AACR Abstract A11: Lower Baseline Levels of Plasma Hepatocyte Growth Factor (HGF), IL-6, and IL-8 Are Correlated With Greater Tumor Shrinkage in Renal Cell Carcinoma Patients Treated With Pazopanibin 


Dr. Herbert A. Fritsche of MD Anderson Cancer Center Discusses his Experience with The AVANTRA Multiplex Biomarker Analyzer from Decision Biomarkers, Inc. At This year's CLAS Meeting held in Boston, MA.


Investigating Assay Precision & Validation on Different Miltiplex Immunoassay Platforms

We are pleased to announce that the article, "Obstacles to
the production of protein microarray cassettes,"
written by the DBI Staff
 and published in Journal of Micro/Nanolithography 8, 033013 (2009),
has been selected for the August 1, 2009 issue of Virtual Journal
of Biological Physics Research.

Founder Jean Montagu Publishes "Obstacles to the Production of Protein Microarray Cassettes"


Putting Photobleaching to Work by Jean Montagu-Full Text


Blood Separator and the Like (completed)- Full Text

 The AVANTRA® Biomarker Workstation is highlighted in the newly published book "Principles of Translational Science in Medicine: From Bench to Bedside", published by Cambridge University Press

Founder Jean "Coco" Montagu Publishes Proceedings Paper with SPIE

Decision Biomarkers Awarded Additional U.S. Patent for Path (R) Protein Array Surface Chemistry

Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers

Decision Biomarkers is published in Genomeweb's Proteomonitor Magazine

Biomarkers Ships First Workstation - Plans to Make Market Debut in January

Decision Biomarkers awarded U.S. Patent for PATH� Protein Array Surface Chemistry

DBI's Portfolio of Technologies for Enabling Faster, Easier Quantification of Protein Biomarkers in Translational Medicine and Adaptive Clinical Trials